CN116059301B - Tea drink for preventing influenza and preparation method thereof - Google Patents
Tea drink for preventing influenza and preparation method thereof Download PDFInfo
- Publication number
- CN116059301B CN116059301B CN202211527221.5A CN202211527221A CN116059301B CN 116059301 B CN116059301 B CN 116059301B CN 202211527221 A CN202211527221 A CN 202211527221A CN 116059301 B CN116059301 B CN 116059301B
- Authority
- CN
- China
- Prior art keywords
- parts
- mixing
- rhizome
- decoction
- pulverizing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010022000 influenza Diseases 0.000 title claims abstract description 39
- 230000003405 preventing effect Effects 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 37
- 238000002156 mixing Methods 0.000 claims abstract description 29
- 241001598107 Imperata Species 0.000 claims abstract description 23
- 239000010231 banlangen Substances 0.000 claims abstract description 23
- 238000011282 treatment Methods 0.000 claims abstract description 20
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 17
- 230000001954 sterilising effect Effects 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims abstract description 16
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 16
- 235000014676 Phragmites communis Nutrition 0.000 claims abstract description 15
- 238000010298 pulverizing process Methods 0.000 claims abstract description 15
- 240000004510 Agastache rugosa Species 0.000 claims abstract description 14
- 241001127714 Amomum Species 0.000 claims abstract description 14
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 239000011259 mixed solution Substances 0.000 claims abstract description 13
- 238000004806 packaging method and process Methods 0.000 claims abstract description 13
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 9
- 238000004108 freeze drying Methods 0.000 claims abstract description 8
- 239000000243 solution Substances 0.000 claims abstract description 8
- 241001529821 Agastache Species 0.000 claims abstract description 7
- 241000628997 Flos Species 0.000 claims abstract description 7
- 238000003756 stirring Methods 0.000 claims abstract description 7
- 239000002775 capsule Substances 0.000 claims abstract description 5
- 244000269722 Thea sinensis Species 0.000 claims abstract 5
- 235000013616 tea Nutrition 0.000 claims description 43
- 241000576429 Forsythia suspensa Species 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 6
- 241000213006 Angelica dahurica Species 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000000748 compression moulding Methods 0.000 claims 3
- 239000002552 dosage form Substances 0.000 claims 3
- 239000000463 material Substances 0.000 abstract description 4
- 241001122767 Theaceae Species 0.000 description 20
- 230000000694 effects Effects 0.000 description 11
- 210000002784 stomach Anatomy 0.000 description 10
- 206010047700 Vomiting Diseases 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 230000009182 swimming Effects 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 7
- 239000008187 granular material Substances 0.000 description 7
- 230000002265 prevention Effects 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000008673 vomiting Effects 0.000 description 6
- 239000003443 antiviral agent Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 229960003971 influenza vaccine Drugs 0.000 description 4
- 235000019605 sweet taste sensations Nutrition 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 238000002255 vaccination Methods 0.000 description 4
- 201000000297 Erysipelas Diseases 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 201000009240 nasopharyngitis Diseases 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 206010036067 polydipsia Diseases 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 241000712461 unidentified influenza virus Species 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010016946 Food allergy Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000009798 acute exacerbation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses tea drink for preventing influenza and a preparation method thereof, and belongs to the technical field of tea drinks. The material is prepared from the following raw materials in parts by weight: 1-3 parts of honeysuckle, 1-4 parts of weeping forsythiae capsule, 1-2 parts of radix isatidis, 2-3 parts of reed rhizome, 2-3 parts of cogongrass rhizome, 2-4 parts of wrinkled gianthyssop herb, 2-5 parts of radix angelicae and 1 part of tsaoko amomum fruit. The preparation method comprises the following steps: mixing radix Isatidis, rhizoma Phragmitis and lalang grass rhizome at a certain proportion, pulverizing into coarse powder, decocting with 3-6 times of water for 30-45min, decocting for 2-4 times, and mixing decoctions; mixing flos Lonicerae, fructus forsythiae, herba Agastaches, radix Angelicae Dahuricae and fructus Tsaoko at a certain ratio, and pulverizing to obtain fine powder; mixing the decoction with the fine powder according to the proportion, adding 1-4 times of water by volume of the mixed solution, stirring uniformly, and concentrating in vacuum at 40-60 ℃; freeze-drying the concentrated solution, and preparing the dried sample into granular tea drink; ozone is adopted for sterilization treatment; quantitatively packaging to obtain the product.
Description
Technical Field
The invention relates to the technical field of tea drinks, in particular to tea drink for preventing influenza and a preparation method thereof.
Background
Influenza is an acute respiratory infection caused by influenza virus, is a disease with strong infectivity and high transmission speed, can show symptoms such as high fever, purulent phlegm, severe cough and/or dyspnea, and can also show heart failure, shock and the like when serious. In view of the limitations of the current human medical level, conventional treatments are mostly injection of antiviral drugs or prevention of influenza.
Vaccination is the most economical and effective method of preventing influenza, but one vaccination with influenza does not represent a "life-long benefit", and because of the wide variety of viruses and the potential for variation, influenza vaccines are injected once a year. The efficacy of influenza vaccines lasts approximately one year, and over the last year vaccination is still needed to achieve protection. And after the influenza vaccine is injected, antibodies can be produced after half a month, so that the aim of prevention is achieved, and the influenza virus cannot be resisted before the antibodies are produced. In addition, patients with ovalbumin allergy, acute exacerbation and fever of acute disease, severe chronic disease, uncontrolled epilepsy and other progressive neurological diseases, and those with a history of Ji Lanba Rayleigh syndrome, etc. cannot be vaccinated with influenza vaccines. From the foregoing, it can be seen that there are also major limitations to vaccination against influenza.
At present, in the antiviral drugs on the market, the direct treatment effect on the viral influenza is less, and most influenza is cured by the immunity of the human body; moreover, long-term administration of antiviral drugs causes resistance to viruses, further reducing the therapeutic effect and even adversely affecting the human body itself. Meanwhile, in order to reduce the occurrence of antiviral drug resistant strains, the prevention by using antiviral drugs in a large range or conventionally is not recommended.
Along with the pursuit of healthy life style, disease prevention by disease treatment has become a popular treatment mode for people. In China, chinese herbal medicine is rich in resources, has increasingly obvious effect on prevention and treatment of serious diseases as a traditional Chinese medicine for 5000 years, is milder in medicine property and can treat the root cause compared with western medicines, so that development of a tea drink with influenza prevention effect is significant for people with poor resistance or cold initial stage.
Disclosure of Invention
The tea drink for preventing influenza provided by the invention can be used for a long time, can effectively improve body functions, strengthen immunity, effectively prevent influenza and is suitable for general people; in addition, the invention also provides a preparation method of the tea beverage, which adopts a corresponding treatment method aiming at different raw materials, keeps special faint scent on the basis of guaranteeing the extraction of active ingredients, has fresh and sweet taste, can increase the drinking willingness, and is suitable for long-term drinking. The technical scheme provided by the invention is as follows:
on one hand, the invention provides a tea drink for preventing influenza, which is prepared from the following raw materials in parts by weight: 1-3 parts of honeysuckle, 1-4 parts of weeping forsythiae capsule, 1-2 parts of radix isatidis, 2-3 parts of reed rhizome, 2-3 parts of cogongrass rhizome, 2-4 parts of wrinkled gianthyssop herb, 2-5 parts of radix angelicae and 1 part of tsaoko amomum fruit. Decocting radix Isatidis, rhizoma Phragmitis and lalang grass rhizome to obtain decoction, mixing the decoction with the medicinal powder, vacuum concentrating at low temperature, lyophilizing, pulverizing, and shaping to obtain granule tea beverage. Specifically, the radix isatidis, the reed rhizome and the cogongrass rhizome have more water-soluble components, and most of the effective components can be obtained by decoction. The honeysuckle, the weeping forsythia, the wrinkled gianthyssop herb, the dahurian angelica root and the tsaoko amomum fruit have volatile components, and are decomposed after being heated, so that the loss of active ingredients is more, and the decoction is not performed. More effective component substances in the medicinal materials can be extracted through decoction and powdering treatment. The tea beverage in the form of granule is prepared by low-temperature vacuum concentration and freeze-drying, so that the decomposition of active ingredients and the decomposition or change of faint scent ingredients are avoided.
The following description of the components is provided:
honeysuckle flower, sweet and cold. Enter lung, heart and stomach meridians; clearing heat and detoxicating, dispelling wind and heat; can be used for treating carbuncle, furuncle, pharyngitis, erysipelas, dysentery with blood, wind-heat type common cold, and epidemic febrile disease. The modern pharmacological research shows that honeysuckle has a certain inhibition effect on various bacteria, is a typical broad-spectrum antibacterial drug, has the effects of resisting influenza virus, respiratory syncytial virus, adenovirus and herpes virus, and has obvious immunity enhancing effect.
Fructus forsythiae, bitter and slightly cold. Enter the lung, heart and small intestine meridians; clearing away heat and toxic materials, detumescence, resolving hard mass, and dispelling pathogenic wind and heat. Can be used for treating carbuncle, scrofula, acute mastitis, erysipelas, wind-heat type common cold, epidemic febrile disease, excessive heat, polydipsia, coma, speckle, and stranguria due to heat.
Radix Isatidis, bitter and cold. It enters heart and stomach meridians. Clear away heat and toxic materials, cool blood and relieve sore throat. Can be used for treating epidemic febrile, fever, pharyngalgia, epidemic parotitis, throat ulcer, erysipelas, carbuncle, and swelling.
Reed rhizome, rhizoma Phragmitis, sweet and cold. Enter lung and stomach meridians; clearing heat and purging fire, promoting fluid production and quenching thirst, relieving restlessness, preventing vomiting, and promoting urination, and can be used for treating pyretic dysphoria and polydipsia, cough due to lung heat, carbuncle and vomiting due to lung, vomiting due to stomach heat, and stranguria due to heat.
Lalang grass rhizome, rhizoma Imperatae, sweet and cold. Enter lung, stomach and bladder meridians. Cool blood and stop bleeding, clear heat and induce diuresis. Can be used for treating hematemesis, epistaxis, hematuria, pyretic disease, polydipsia, jaundice due to damp-heat, edema, oliguria, and stranguria due to heat.
Huo Xiang, pungent and slightly warm. Enter spleen, stomach and lung meridians. Aromatic, turbid-qi transforming, middle energizer regulating, vomiting relieving, summer-heat relieving. Can be used for treating damp obstruction in middle energizer, gastric fullness and emesis, summer-heat and dampness exterior syndrome, damp warm beginning, fever and listlessness, chest distress and discomfort, cold dampness and summer-heat obstruction, abdominal pain and vomiting and diarrhea, and nasosinusitis headache.
Dahurian angelica root, radix Angelicae Dahuricae, pungent and warm. The stomach, large intestine and lung channels; relieving exterior syndrome, dispelling cold, dispelling pathogenic wind, relieving pain, dredging nasal orifices, eliminating dampness, stopping leukorrhagia, relieving swelling, and expelling pus, and can be used for treating common cold, headache, glauber bone pain, nasal obstruction, nasal discharge, allergic rhinitis, nasosinusitis, toothache, leukorrhagia, and pyocutaneous disease.
Fructus Tsaoko, pungent and warm. Enter spleen and stomach meridians. Remove dampness and warm middle energizer, check malaria and remove phlegm. Can be used for treating internal cold and dampness, abdominal distention and pain, distention and fullness, emesis, malaria, fever, and epidemic febrile disease. The medicines are combined together to play the roles of clearing heat, detoxicating and eliminating pathogenic factors.
Honeysuckle, weeping forsythiae capsule and radix isatidis all have the effects of clearing heat and detoxicating, reed rhizome purging fire, cogongrass rhizome promoting urination, wrinkled gianthyssop herb for stopping vomiting, dahurian angelica root for dispelling cold and tsaoko amomum fruit for drying dampness. The tea beverage is free of other adjuvants, sweetener, etc., and has sweet taste and no bitter taste after being combined and made into product. Part of raw materials have faint scent (such as sweet taste and faint scent of honeysuckle after soaking in water), and the raw materials are combined and made into products to have faint scent of flowers.
Specifically, the tea drink for preventing influenza is prepared from the following raw materials in parts by weight: 2 parts of honeysuckle, 2 parts of weeping forsythia, 2 parts of radix isatidis, 3 parts of reed rhizome, 3 parts of cogongrass rhizome, 4 parts of wrinkled gianthyssop, 5 parts of radix angelicae and 1 part of tsaoko amomum fruit.
Specifically, the tea drink for preventing influenza is prepared from the following raw materials in parts by weight: 1 part of honeysuckle, 1 part of weeping forsythia, 1 part of radix isatidis, 1 part of reed rhizome, 2 parts of cogongrass rhizome, 3 parts of wrinkled gianthyssop, 2 parts of radix angelicae and 1 part of tsaoko amomum fruit.
Specifically, the tea drink for preventing influenza is prepared from the following raw materials in parts by weight: 3 parts of honeysuckle, 4 parts of weeping forsythia, 2 parts of radix isatidis, 2 parts of reed rhizome, 2 parts of cogongrass rhizome, 2 parts of wrinkled gianthyssop, 3 parts of radix angelicae and 1 part of tsaoko amomum fruit.
Preferably, the granular tea beverage is sterilized with ozone. Ozone sterilization has several effects: firstly, the sterilization effect is better; and secondly, high temperature is not needed, so that high-temperature volatilization of effective substances and volatilization or change of faint scent substances are avoided.
In another aspect, the present invention also provides a preparation method of the tea beverage for preventing influenza, which comprises the following steps:
(1) The preparation of the decoction comprises the following steps: mixing radix Isatidis, rhizoma Phragmitis and lalang grass rhizome at a certain proportion, pulverizing into coarse powder, decocting with 3-6 times of water for 30-45min, decocting for 2-4 times, and mixing decoctions.
(2) Preparing medicinal powder: mixing flos Lonicerae, fructus forsythiae, herba Agastaches, radix Angelicae Dahuricae and fructus Tsaoko at a certain ratio, and pulverizing to obtain fine powder (i.e. the above mentioned medicinal powder).
(3) Concentrating: mixing the decoction with the fine powder according to a certain proportion to obtain a mixed solution, adding 1-4 times of water to ensure uniformity of the fine powder completely dissolved in the decoction, stirring, and vacuum concentrating at 40-60deg.C to 1/8-1/2 of the volume of the mixed solution.
(4) Preparing particles: freeze-drying the concentrated solution, crushing the dried sample into superfine powder, and pressing to form tea beverage in a granule form; the preparation method of the granule is the same as that of the conventional granule.
(5) And (3) sterilization: ozone is adopted for sterilization treatment.
(6) And (3) packaging: quantitatively packaging to obtain the product.
Wherein in step (1), the coarse powder is smaller than 10 mesh or crushed to pass through a first sieve to be not less than 95%. In the step (2), the size of the fine powder is 10-50 meshes. In the step (4), crushing to a size smaller than 200 meshes.
Wherein, in the step (5), the conditions of the ozone sterilization treatment are as follows: the treatment time is 2-4 hours, and the ozone concentration is 8-20ppm.
Specifically, the preparation method of the tea drink for preventing influenza comprises the following steps:
(1) The preparation of the decoction comprises the following steps: mixing radix Isatidis, rhizoma Phragmitis and lalang grass rhizome at a certain proportion, pulverizing into coarse powder smaller than 10 mesh, adding 5 times of water for each time, decocting for 30-45min, decocting for 3 times, and mixing decoctions.
(2) Preparing medicinal powder: mixing flos Lonicerae, fructus forsythiae, herba Agastaches, radix Angelicae Dahuricae and fructus Tsaoko at a certain ratio, and pulverizing to obtain 10-50 mesh fine powder.
(3) Concentrating: mixing the decoction with the fine powder according to the proportion, adding water with the volume of 3 times of that of the mixed solution, stirring uniformly, and concentrating in vacuum at 40-60 ℃ to 1/6 of the volume of the mixed solution.
(4) Preparing particles: freeze-drying the concentrated solution, and crushing and press-forming the dried sample to obtain the tea beverage in the form of granule.
(5) And (3) sterilization: ozone is adopted for sterilization treatment, the treatment time is 2-4 hours, and the ozone concentration is 12ppm.
(6) And (3) packaging: quantitatively packaging in a sterile workshop according to 5 g/bag to obtain the product.
The method of the invention has the following beneficial effects:
(1) Can effectively improve body functions, increase physical strength, strengthen immunity, effectively prevent influenza and is suitable for general people;
(2) Has sweet taste and faint scent, and can be drunk by people for a long time.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, embodiments of the present invention will be described in further detail below.
Example 1
The embodiment 1 provides a tea drink for preventing influenza and a preparation method thereof, wherein the tea drink is prepared from the following raw materials in parts by weight: 2 parts of honeysuckle, 2 parts of weeping forsythia, 2 parts of radix isatidis, 3 parts of reed rhizome, 3 parts of cogongrass rhizome, 4 parts of wrinkled gianthyssop, 5 parts of radix angelicae and 1 part of tsaoko amomum fruit. The preparation method comprises the following steps:
(1) The preparation of the decoction comprises the following steps: mixing radix Isatidis, rhizoma Phragmitis and lalang grass rhizome at a certain proportion, pulverizing into coarse powder smaller than 10 mesh, adding 5 times of water, decocting for 30-45min for 3 times, and mixing decoctions.
(2) Preparing medicinal powder: mixing flos Lonicerae, fructus forsythiae, herba Agastaches, radix Angelicae Dahuricae and fructus Tsaoko at a certain ratio, and pulverizing to obtain 10-50 mesh fine powder.
(3) Concentrating: mixing the decoction with the fine powder according to the proportion, adding water with the volume of 3 times of that of the mixed solution, stirring uniformly, and concentrating in vacuum at 40-60 ℃ to 1/6 of the volume of the mixed solution.
(4) Preparing particles: freeze-drying the concentrated solution, and crushing and press-forming the dried sample to obtain the tea beverage in the form of granule.
(5) And (3) sterilization: ozone is adopted for sterilization treatment, the treatment time is 2-4 hours, and the ozone concentration is 12ppm.
(6) And (3) packaging: quantitatively packaging in a sterile workshop according to 5 g/bag to obtain the product.
Example 2
The embodiment 2 provides a tea drink for preventing influenza and a preparation method thereof, wherein the tea drink is prepared from the following raw materials in parts by weight: 1 part of honeysuckle, 1 part of weeping forsythia, 1 part of radix isatidis, 1 part of reed rhizome, 2 parts of cogongrass rhizome, 3 parts of wrinkled gianthyssop, 2 parts of radix angelicae and 1 part of tsaoko amomum fruit. The preparation method is the same as in example 1.
Example 3
The embodiment 3 provides a tea drink for preventing influenza and a preparation method thereof, wherein the tea drink is prepared from the following raw materials in parts by weight: 3 parts of honeysuckle, 4 parts of weeping forsythia, 2 parts of radix isatidis, 2 parts of reed rhizome, 2 parts of cogongrass rhizome, 2 parts of wrinkled gianthyssop, 3 parts of radix angelicae and 1 part of tsaoko amomum fruit. The preparation method is the same as in example 1.
Verification example
1. Test for drinking
5g of the tea drinks of examples 1-3 were taken and placed in 500ml glasses, respectively, and brewed with 300ml boiling water for 5min, and tasting was started when the temperature was reduced to 35.+ -. 5 ℃ and the taste, smell and scores of the different tea drinks were compared, and the results are shown in Table 1:
table 1 mouthfeel test results
Scoring criteria: 1. bitter and astringent; 2. light taste; 3. the fragrance in the mouth is improved; 4. balanced bitter and sweet, and sweet aftertaste; 5. the product is mellow in taste.
As can be seen from Table 1, the tea beverage of the present patent has a sweet or light taste and a faint scent.
2. Influenza prevention test
In order to study the anti-influenza curative effect of the traditional Chinese medicine tea, 100 people of 10-60 years old are selected during the winter influenza epidemic period, and men and women respectively account for half, wherein 10-20 years old 30 people, 20-40 years old 30 people and 40-50 years old 40 people. 100 people are randomly divided into 4 groups according to age groups (namely the 3 age groups), one group, two groups and three groups are respectively brewed with the tea drinks of the examples 1, 2 and 3 every day, and the four groups do not drink tea drinks, and no other medicines capable of preventing and treating influenza are taken in the period. The number of influenza times of the people in 3 months is counted, and the influenza morbidity conditions of the two groups of people are respectively observed, and the results are shown in Table 2:
TABLE 2 influenza prevention Condition list
As can be seen from Table 2, the tea beverages of examples 1-3 were consumed at a low ratio of influenza, whereas the population not consumed the tea beverages had a high ratio of influenza, indicating that the tea beverages of examples 1-3 had influenza preventing effects.
3. Fatigue resistance test
40 mice were screened and divided into 4 groups of 10 mice each, and a load swim test was performed. Taking the products of examples 1-3, infusing with boiling water, concentrating the aqueous solution, and taking the same dosage of the medicines for one month according to the weight of 1ml/50g by stomach infusion, taking the same dosage of physiological saline for stomach infusion by a control group, loading 5% weight lead wire on the root of the tail of a mouse tested object for 30min at last time, putting the mouse tested object into a swimming box for swimming, and measuring the load swimming time of each group of mice. The measured swimming time of the load is subjected to variance alignment test, the requirement of variance alignment is met, statistical treatment is performed by a two-by-two comparison method of average numbers between a plurality of experimental groups and a control group in a single-factor variance analysis method, and the results are shown in Table 3:
TABLE 3 mouse weight bearing swimming time
As can be seen from Table 3, the average swimming time of groups 1-3 was prolonged as compared with the control group, indicating that the prepared tea beverage has antifatigue effect and can enhance the function. Wherein, the swimming time of one group of mice is longest, and the average swimming time of one group of mice, two groups of mice and three groups of mice reaches more than 2 times of that of a control group. The above results indicate that examples 1-3 all have anti-fatigue effects.
In Table 1, examples 1 and 3 are preferred; in Table 2, example 2 is preferred; in Table 3, example 1 is preferred. The formulation of example 2 was used with the corresponding formulation being adjusted as required, if better influenza preventing effect was desired.
The foregoing description of the preferred embodiments of the invention is not intended to limit the invention to the precise form disclosed, and any such modifications, equivalents, and alternatives falling within the spirit and scope of the invention are intended to be included within the scope of the invention.
Claims (7)
1. The tea drink for preventing influenza is characterized by being prepared from the following raw materials in parts by weight: 1-3 parts of honeysuckle, 1-4 parts of weeping forsythiae capsule, 1-2 parts of radix isatidis, 2-3 parts of reed rhizome, 2-3 parts of cogongrass rhizome, 2-4 parts of wrinkled gianthyssop herb, 2-5 parts of dahurian angelica root and 1 part of tsaoko amomum fruit, wherein the radix isatidis, reed rhizome and cogongrass rhizome are prepared into decoction, the honeysuckle, weeping forsythiae capsule, wrinkled gianthyssop herb, dahurian angelica root and tsaoko amomum fruit are prepared into medicinal powder, and the decoction and the medicinal powder are mixed, concentrated in vacuum at low temperature, freeze-dried, crushed and molded to obtain granular tea drink;
the preparation method comprises the following steps:
(1) The preparation of the decoction comprises the following steps: mixing radix Isatidis, rhizoma Phragmitis and lalang grass rhizome at a certain proportion, pulverizing into coarse powder, decocting with 3-6 times of water for 30-45min, decocting for 2-4 times, and mixing decoctions;
(2) Preparing medicinal powder: mixing flos Lonicerae, fructus forsythiae, herba Agastaches, radix Angelicae Dahuricae and fructus Tsaoko at a certain ratio, and pulverizing to obtain fine powder;
(3) Concentrating: mixing the decoction with the fine powder according to the proportion, adding water with the volume of 1-4 times of that of the mixed solution, stirring uniformly, and concentrating in vacuum at 40-60 ℃ to 1/8-1/2 of that of the mixed solution;
(4) Preparing particles: freeze-drying the concentrated solution, and crushing and compression molding the dried sample to obtain tea beverage in a granular dosage form;
(5) And (3) sterilization: ozone is adopted for sterilization treatment;
(6) And (3) packaging: quantitatively packaging to obtain the product.
2. The tea beverage for preventing influenza according to claim 1, which is prepared from the following raw materials in parts by weight: 2 parts of honeysuckle, 2 parts of weeping forsythia, 2 parts of radix isatidis, 3 parts of reed rhizome, 3 parts of cogongrass rhizome, 4 parts of wrinkled gianthyssop, 5 parts of radix angelicae and 1 part of tsaoko amomum fruit.
3. The tea beverage for preventing influenza according to claim 1, which is prepared from the following raw materials in parts by weight: 3 parts of honeysuckle, 4 parts of weeping forsythia, 2 parts of radix isatidis, 2 parts of reed rhizome, 2 parts of cogongrass rhizome, 2 parts of wrinkled gianthyssop, 3 parts of radix angelicae and 1 part of tsaoko amomum fruit.
4. A method for preparing a tea beverage for preventing influenza as claimed in any one of claims 1 to 3, comprising the steps of:
(1) The preparation of the decoction comprises the following steps: mixing radix Isatidis, rhizoma Phragmitis and lalang grass rhizome at a certain proportion, pulverizing into coarse powder, decocting with 3-6 times of water for 30-45min, decocting for 2-4 times, and mixing decoctions;
(2) Preparing medicinal powder: mixing flos Lonicerae, fructus forsythiae, herba Agastaches, radix Angelicae Dahuricae and fructus Tsaoko at a certain ratio, and pulverizing to obtain fine powder;
(3) Concentrating: mixing the decoction with the fine powder according to the proportion, adding water with the volume of 1-4 times of that of the mixed solution, stirring uniformly, and concentrating in vacuum at 40-60 ℃ to 1/8-1/2 of that of the mixed solution;
(4) Preparing particles: freeze-drying the concentrated solution, and crushing and compression molding the dried sample to obtain tea beverage in a granular dosage form;
(5) And (3) sterilization: ozone is adopted for sterilization treatment;
(6) And (3) packaging: quantitatively packaging to obtain the product.
5. The process of claim 4 wherein in step (1), the coarse powder is less than 10 mesh in size; in the step (2), the size of the fine powder is 10-50 meshes.
6. The method according to claim 4, wherein in the step (5), the conditions for the ozone sterilization treatment are: the treatment time is 2-4 hours, and the ozone concentration is 8-20ppm.
7. The method of manufacturing according to claim 4, comprising the steps of:
(1) The preparation of the decoction comprises the following steps: mixing radix Isatidis, rhizoma Phragmitis and lalang grass rhizome at a certain proportion, pulverizing into coarse powder smaller than 10 mesh, adding 5 times of water for each time, decocting for 30-45min, decocting for 3 times, and mixing decoctions;
(2) Preparing medicinal powder: mixing flos Lonicerae, fructus forsythiae, herba Agastaches, radix Angelicae Dahuricae and fructus Tsaoko at a certain ratio, and pulverizing to obtain 10-50 mesh fine powder;
(3) Concentrating: mixing the decoction with the fine powder according to the proportion, adding water with the volume of 3 times of that of the mixed solution, stirring uniformly, and concentrating in vacuum at 40-60 ℃ to 1/6 of the volume of the mixed solution;
(4) Preparing particles: freeze-drying the concentrated solution, and crushing and compression molding the dried sample to obtain tea beverage in a granular dosage form;
(5) And (3) sterilization: sterilizing with ozone for 2-4 hr to obtain ozone concentration of 12ppm;
(6) And (3) packaging: quantitatively packaging to obtain the product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211527221.5A CN116059301B (en) | 2022-12-01 | 2022-12-01 | Tea drink for preventing influenza and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211527221.5A CN116059301B (en) | 2022-12-01 | 2022-12-01 | Tea drink for preventing influenza and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116059301A CN116059301A (en) | 2023-05-05 |
CN116059301B true CN116059301B (en) | 2024-02-13 |
Family
ID=86181059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211527221.5A Active CN116059301B (en) | 2022-12-01 | 2022-12-01 | Tea drink for preventing influenza and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116059301B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111388621A (en) * | 2020-06-01 | 2020-07-10 | 北京国医九和医药科技有限公司 | Traditional Chinese medicine epidemic prevention bag |
-
2022
- 2022-12-01 CN CN202211527221.5A patent/CN116059301B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111388621A (en) * | 2020-06-01 | 2020-07-10 | 北京国医九和医药科技有限公司 | Traditional Chinese medicine epidemic prevention bag |
CN113750199A (en) * | 2020-06-01 | 2021-12-07 | 北京国医九和医药科技有限公司 | Traditional Chinese medicine epidemic prevention bag |
Non-Patent Citations (2)
Title |
---|
"易阳通元"防治新冠肺炎作用探讨;张瑞雪等;《现代中医药》;第40卷(第03期);第1-6页 * |
中医药防治人禽流感专家建议;中华中医药学会;《中华中医药学刊》;第25卷(第07期);第1535-1536页 * |
Also Published As
Publication number | Publication date |
---|---|
CN116059301A (en) | 2023-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102845570B (en) | Herbal tea for clearing heat and reducing internal heat and preparation method thereof | |
CN104435944A (en) | Traditional Chinese medicine composition for treating infantile cough and preparation method thereof | |
CN107397934A (en) | A kind of body-building kidney-reinforcing medicinal liquor | |
CN1251732C (en) | Chinese medicine for treating intrapulmonic infection and SARS | |
CN103656397A (en) | Compound medicine for treating chronic pharyngitis | |
CN108813501A (en) | With the relieving cough and reducing sputum health honey paste relievingd asthma and adjust function of human body of clearing heat and moistening lung | |
CN107625828A (en) | A kind of health protection tea for auxiliary treatment chronic pharyngitis, preparation method and application | |
CN104398938A (en) | Traditional Chinese medicine for treating wind-heat invading lung lobar pneumonia and preparation method | |
CN103920027A (en) | Medicament for treating acute jaundice hepatitis B and preparation method thereof | |
CN110652544A (en) | Pharmaceutical composition for treating rhinitis and preparation method thereof | |
CN103007207A (en) | Chinese medicament for preventing and treating infectious serositis of duck | |
CN116059301B (en) | Tea drink for preventing influenza and preparation method thereof | |
CN102919452A (en) | Throat clearing and nourishing tea and preparation method thereof | |
CN104983968A (en) | Pyretolysis traditional Chinese medicine composition and preparation method | |
CN104127751A (en) | Traditional Chinese medicine for treating chronic bronchitis caused by phlegm-dampness lung attacking and preparation method thereof | |
CN104258252A (en) | Pharmaceutical composition for treating duck virus hepatitis and preparation method thereof | |
CN103520348A (en) | External traditional Chinese medicine oil for treating haemorrhoids | |
CN106605818B (en) | Instant granule of Shangqingyin and its preparation method | |
CN106421257B (en) | It is a kind of to treat Chinese and Western medicine particle of flu and preparation method thereof | |
CN113425767B (en) | Traditional Chinese medicine composition for treating pneumonia | |
CN103690771B (en) | Be used for the treatment of medicine of lamb colibacillosis and preparation method thereof | |
CN103230580B (en) | Traditional Chinese medicine composition for preventing and treating infectious serositis of duck | |
CN103566005A (en) | Traditional Chinese medicine for treating poultry virus diseases and preparation method thereof | |
CN101006811A (en) | Bear's ball tea and its preparation method | |
CN105412679A (en) | Traditional Chinese medicine preparation for treating lung abscess and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |